Multi-Symptom Nighttime Interactions
There are 684 drugs known to interact with Multi-Symptom Nighttime (acetaminophen / dextromethorphan / doxylamine / pseudoephedrine), along with 17 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 103 are major, 561 are moderate, and 20 are minor.
- View all 684 medications that may interact with Multi-Symptom Nighttime
- View Multi-Symptom Nighttime alcohol/food interactions (2)
- View Multi-Symptom Nighttime disease interactions (17)
Most frequently checked interactions
View interaction reports for Multi-Symptom Nighttime (acetaminophen / dextromethorphan / doxylamine / pseudoephedrine) and the medicines listed below.
- acetaminophen / butalbital / caffeine
- albuterol
- Allegra (fexofenadine)
- amitriptyline
- azelastine nasal
- baclofen
- benzonatate
- benztropine
- buspirone
- Celebrex (celecoxib)
- etonogestrel
- famotidine
- ferrous sulfate
- Flector Patch (diclofenac topical)
- Flexeril (cyclobenzaprine)
- fluticasone
- gabapentin
- hydrocodone
- ibuprofen
- Lyrica (pregabalin)
- Maxalt (rizatriptan)
- meloxicam
- metaxalone
- metformin
- MethylPREDNISolone Dose Pack (methylprednisolone)
- montelukast
- NuvaRing (ethinyl estradiol / etonogestrel)
- ondansetron
- oxycodone
- pantoprazole
Multi-Symptom Nighttime alcohol/food interactions
There are 2 alcohol/food interactions with Multi-Symptom Nighttime (acetaminophen / dextromethorphan / doxylamine / pseudoephedrine).
Multi-Symptom Nighttime disease interactions
There are 17 disease interactions with Multi-Symptom Nighttime (acetaminophen / dextromethorphan / doxylamine / pseudoephedrine) which include:
- alcoholism
- liver disease
- depression
- cardiovascular disease
- PKU
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- resp depression
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
More about Multi-Symptom Nighttime (acetaminophen / dextromethorphan / doxylamine / pseudoephedrine)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.